Jeffrey L Smith

10PUBLICATIONS
36CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 20, 2025
Chemoproteomic Profiling of C. albicans for Characterization of Anti-fungal Kinase Inhibitors.

David J Shirley, Meganathan Nandakumar, Aurora Cabrera

|Sep 14, 2024
Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2.

Han Wee Ong, Xuan Yang, Jeffery L Smith

|Mar 28, 2024
Synthesis of 5-Benzylamino and 5-Alkylamino-Substituted Pyrimido[4,5-c]quinoline Derivatives as CSNK2A Inhibitors with Antiviral Activity.

Kesatebrhan Haile Asressu, Jeffery L Smith, Rebekah J Dickmander

|Dec 18, 2023
Identification of 4-(6-((2-methoxyphenyl)amino)pyrazin-2-yl)benzoic acids as CSNK2A inhibitors with antiviral activity and improved selectivity over PIM3.

Kareem A Galal, Andreas Krämer, Benjamin G Strickland

|Jul 25, 2023
Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology.

Anna Castano, Margaux Silvestre, Carrow I Wells

|Jun 09, 2023
Optimization of 3-Cyano-7-cyclopropylamino-pyrazolo[1,5-a]pyrimidines Toward the Development of an In Vivo Chemical Probe for CSNK2A.

Xuan Yang, Han Wee Ong, Rebekah J Dickmander

Pageof 2

Frequent Collaborators

6 joint publications

Alison D Axtman

6 joint publications

Timothy M Willson

4 joint publications

David H Drewry

4 joint publications

Frances M Potjewyd